Ultrasound in obstetrics

Danforth's Obstetrics and Gynecology: Tenth Edition

Volumn , Issue , 2012, Pages 137-151

  Pandipati, Santosh ^a   Hobbins, John C ^b  

^a Northwest Perinatal Center   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84969972595     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (56)

1. American Institute of Ultrasound in Medicine. AIUM practice guidelines for the performance of an antepartum obstetric ultrasound examination. Laurel, MD:Alum, 2007;1-13.
2. American Institute of Ultrasound in Medicine. AIUM official statement:limited obstetrical ultrasound.: Laurel, MD:Author, approved October 7, 1997.
3. Goldstein SR. Significance of cardiac activity in very early embryos. Obstet Gynecol 1992;80:670-672.
4. Goldstein SR, Snyder JR, Watson C, et al. Very early pregnancy detection with endovaginal ultrasound. Obstet Gynecol 1988;72:200- 204.
5. Goldstein SR, Wolfson R. Endovaginal ultrasonographic measurement of early embryonic size as a means of assessing gestational age. J Ultrasound Med 1994;13:27-31.
6. Souka AP, Pilalis A, Kavalakis I, et al. Screening for major structural anomalies at the 11-to-14 week ultrasound scan. Am J ObstetGynecol 2006;194:393-396.
7. Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss in pregnancy. N Engl J Med 1988;319:189-194.
8. Breeze AC, Dey PK, Lees CC, et al. Obstetric and neonatal outcomes in apparently isolated mild fetal ventriculomegaly. J Perinat Med 2005;33:236-240.
9. Goldstein I, Copel JA, Makhoul EI. Mild cerebral ventriculomegaly in fetuses:characteristics and outcome. FetalDiagn Ther 2005;20:281- 284.
10. Pilu G, Hobbins JC. Sonography offetal cerebrospinal anomalies. Pre- natDiag 2002;22:321-330.
11. Ryu JM, Kim MY, Choi HK, et al. Three-vessel view of the fetal upper mediastinum:an easy means of detecting abnormalities of the ventricular outflow tracts and great arteries during obstetric scanning. Ultrasound ObstetGynecol 1997;9:173-182.
12. Yagal S, Arbel R, Anteby EY, et al. The three vessels and trachea view (3VT) in fetal cardiac scanning. Ultrasound Obstet Gynecol 2002;20:340-345.
13. Lennon CA, Gray DL. Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population. ObstetGynecol 1999;94:562-566.
14. Becker RH, Vonk R, Mende BC, et al. The relevance of placental location at 20-23 gestational weeks for prediction of placenta previa at delivery evaluation of 8650 cases. Ultrasound Obstet Gynecol 2001;17:496-501.
15. Benirschke K, Kaufmann P, Baergen R. Pathology of the human placenta, 5th ed. New York:Springer-Verlag New York, Inc., 2006.
16. Comstock CH. Antenatal diagnosis of placenta accreta:a review. Ultrasound Obstet Gynecol 2005;26:89-96.
17. Kupferminc MJ, Tamura RK, Wigton TR, et al. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1993;82:266-269.
18. Simon-Bouy B, Mueller F. French Collaborative Group. Hypere- chogenic fetal bowel and Down syndrome:results of a French collaborative study based on 680 prospective cases. Prenat Diag 2002;22:189-192.
19. Broadley T, McCugo J, Morgan I, et al. The 4 year outcome following the demonstration of bilateral renal pelvic dilatation on prenatal renal ultrasound. BrJ Radiol 1999;72:265-270.
20. Persutte WH, Hussey M, Chyu J, et al. Striking findings concerning the variability in the measurement of the fetal renal collecting system. Ultrasound Obstet Gynecol 2000;15:186-190.
21. Dugoff L, Thieme G, Hobbins JC. Skeletal anomalies. Clin Perinatol 2000;27:979-1005.
22. Hanley ML, Vintzileos AM. Antepartum and intrapartum surveillance of fetal well-being. In:Reece EA, Hobbins JC, eds. Medicine of the fetus and mother, 2nd ed. Philadelphia:Lippincott-Raven Publishers, 1999.
23. Manning FA, Platt LD, Sipos L. Antepartum fetal evaluation:development of a fetal biophysical profile. Am J Obstet Gynecol 1980;136:787-795.
24. Miller DA, Rabello YA, Paul RH. The modified biophysical:antepartum testing in the 1990's. Am J Obstet Gynecol 1996;174:812-817.
25. Vintzileos AM, Fleming AD, Scorza WE, et al. Relationship between fetal biophysical activities and umbilical cord blood gas values. Am J Obstet Gynecol 1991;165:707-713.
26. Baschat AA, Gembruch U, Harmon CR. The sequence of changes in Doppler and biophysical parameters as several fetal growth restriction worsens. Ultrasound Obstet Gynecol 2001;18:571-577.
27. Ferrazzi E, Bozzo M, Rigano S, et al. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol 2002;19:140-146.
28. Francisco RPV, Miyadahira S, Zugaib M, et al. Predicting pH at birth in absent or reverse end diastolic velocity in umbilical arteries. Obstet Gynecol 2006;107:1042-1048.
29. Karsdorp VH, Dirks BK, van der Linden JC, et al. Placenta morphology and absent or reversed end diastolic flow velocities in the umbilical artery:a clinical and morphometrical study. Placenta 1996;17:393- 399.
30. DeVore GR. The role of fetal echocardiography in genetic sonography. Semin Perinatol 2003;27:160-172.
31. Egan JFX. The genetic sonogram in second trimester Down syndrome screening. Clin Obstet Gynecol 2003;46:897-908.
32. Malone FD, Wald NJ, Canick JA, et al., for the First and Second Trimester Evaluation of Risk (FASTER Trial). First- and Second- Trimester Evaluation of Risk (FASTER) trial:principal results ofthe NICHD multicenter Down syndrome screening study. Am J Obstet Gynecol 2003;189:S56.
33. Wald NJ, Rodeck C, Hackshaw AR, et al. First and second trimester antenatal screening for Down's syndrome:the results in the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003;7:1-77.
34. Wapner R, Thom E, Simpson JL, et al., for the First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. First-trimester screening fortrisomies 21 and 18. N Engl J Med 2003;349:1405-1413.
35. Yeo L, Guzman ER, Ananth CV, et al. Prenatal detection of fetal trisomy 18 through abnormal sonographic features. J Ultrasound Med 2003;22:581-590.
36. Heath VC, Southall TR, Souka AP, et al. Cervical length at 23 weeks of gestation:prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 1998;12:312-317.
37. Monteagudo A, Timor-Tritsch IE, eds. Ultrasound and multifetal pregnancy. New York:Parthenon Publishing Group, 1998.
38. Sperling L, Kiil C, Larsen LU, et al. How to identify twins at low risk of spontaneous preterm delivery. Ultrasound Obstet Gynecol 2005;26:138-144.
39. Cohen B, Penning S, Major C, et al. Sonographic prediction of shoulder dystocia in infants of diabetic mothers. Obstet Gynecol 1996;88:10- 13.
40. Hyett JA. Increased nuchal translucency in fetuses with a normal karyotype. PrenatDiag 2002;22:864-868.
41. Sheffield JS, Butler-Koster EL, Casey BM, et al. Maternal diabetes mellitus and infant malformations. Obstet Gynecol 2002;100:925-930.
42. Bower S, Schuchter K, Campbell S. Doppler ultrasound screening as part of routine antenatal scanning:prediction of pre-eclampsia and intrauterine growth retardation. BJOG 1993;100:989-994.
43. Coomarasamy A, Papaioannou S, Gee H, et al. Aspirin for prevention of preeclampsia in women with abnormal uterine artery Doppler:a meta-analysis. Obstet Gynecol 2001;98:861-866.
44. Frusca T, Soregaroli M, Zanelli S, et al. Role of uterine artery Doppler investigation in pregnant women with chronic hypertension. Eur J Obstet Gynecol Reprod Biol 1998;79:47-50.
45. Sekizuka N, Hasegawa I, Takakuwa K, et al. Scoring of uterine artery flow velocity waveform in the assessment of fetal growth restriction and/or pregnancy-induced hypertension. J Matern Fetal Invest 1997;7:197-200.
46. Drakeley A, Roberts D, Alfirevic Z. Cervical cerclage for prevention of preterm delivery:meta-analysis of randomized trials. Am J Obstet Gynecol 2003;102:621-627.
47. Gire C, Fabbianelli P, Nicaise C, et al. Ultrasonographic evaluation of cervical length in pregnancies complicated by preterm premature rupture of membranes. Ultrasound Obstet Gynecol 2002;19:565- 569.
48. Gomez R, Romero R, Medina L, et al. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol 2005;92:350-359.
49. Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal fetal medicine Unit Network. N Engl J Med 1996;334:567-572.
50. Mari G, Deter RL, Carpenter RL. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. J Ultrasound Med 2005;24:1599- 1624.
51. Benacerraf BR, Shipp TD, Bromley B. How sonographic tomography will change the face of fetal ultrasound:a pilot study. J Ultrasound Med 2005;24:371-378.
52. Campbell S. 4D and prenatal bonding:still more questions than answers. Ultrasound Obstet Gynecol 2006;27:243-244.
53. Goncalves L, Lee W, Espinosa J, et al. Three- and 4-dimensional ultrasound in obstetric practice:does it help? J Ultrasound Med 2005;24:1599-1624.
54. Lee W, Deter R, Ebersole JD, et al. Birth weight prediction by threedimensional ultrasonography:fractional limb volume. J Ultrasound Med 2001;20:1283-1292.
55. Ruano R, Joubin L, Sonigo P, et al. Fetal lung volume estimated by 3dimensional ultrasonography and magnetic resonance imaging in cases with isolated congenital diaphragmatic hernia. J Ultrasound Med 2004;23:353-358.
56. Sedgmen B, McMahon C, Cairns D, et al. The impact of twodimensional versus three-dimensional ultrasound exposure on maternal-fetal attachment and maternal health behavior in pregnancy. Ultrasound Obstet Gynecol 2006;27:245-251.